HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$1.94
Day range
$1.84 - $2.10
Year range
$1.00 - $5.01
Market cap
17.19M USD
Avg Volume
46.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.11M | -25.65% |
Net income | -5.20M | -3.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.99M | -6.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.85M | -70.83% |
Total assets | 38.12M | -46.59% |
Total liabilities | 16.71M | -9.90% |
Total equity | 21.41M | — |
Shares outstanding | 9.29M | — |
Price to book | 0.84 | — |
Return on assets | -65.43% | — |
Return on capital | -91.55% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.20M | -3.40% |
Cash from operations | -7.80M | 27.47% |
Cash from investing | 4.67M | 114.90% |
Cash from financing | -173.98K | 55.89% |
Net change in cash | -3.26M | 92.34% |
Free cash flow | -4.39M | 40.78% |
About
Founded
2014
Headquarters
Website
Employees
63
